TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021

Rhea-AI Summary

TELA Bio, Inc. (NASDAQ: TELA), a medical technology company, will report its fourth quarter and full year 2020 financial results on March 24, 2021. The management team will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a corporate update. TELA specializes in innovative tissue reinforcement materials aimed at soft tissue reconstruction, particularly in hernia repair and abdominal wall reconstruction.

MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the company will report fourth quarter and full year 2020 financial results on March 24, 2021. TELA Bio's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.  

Conference Call and Webcast Details
The conference call can be accessed by dialing (855) 548-1219 for participants in the U.S. or Canada and (409) 217-8881 for international callers, using conference ID 8550518. A live and archived webcast of the event can be accessed via the Events & Presentations page of the investor section of TELA's website.

About TELA Bio, Inc.
TELA Bio Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is committed to providing patients with advanced, economically effective biologic material repair solutions to patients to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio’s OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010 
ir@telabio.com

FAQ

When will TELA Bio report its fourth quarter and full year 2020 financial results?

TELA Bio will report its financial results on March 24, 2021.

What time is the TELA Bio conference call regarding financial results?

The conference call will take place at 4:30 p.m. ET on March 24, 2021.

How can I access the webcast for TELA Bio's financial results?

The webcast can be accessed via the Events & Presentations page on TELA's investor website.

What is the focus of TELA Bio's business?

TELA Bio focuses on designing, developing, and marketing innovative tissue reinforcement materials for soft tissue reconstruction.